It is bound 65% to sex hormone-binding globulin (SHBG) and 33% bound weakly to albumin. The amount of testosterone synthesized is regulated by the hypothalamic–pituitary–testicular axis (Figure 2). In addition, the amount of testosterone produced by existing Leydig cells is under the control of LH, which regulates the expression of 17β-hydroxysteroid dehydrogenase. The number of Leydig cells in turn is regulated by luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Testosterone is also synthesized in far smaller total quantities in women by the adrenal glands, thecal cells of the ovaries, and, during pregnancy, by the placenta. When testosterone levels are low, gonadotropin-releasing hormone (GnRH) is released by the hypothalamus, which in turn stimulates the pituitary gland to release FSH and LH. Studies have shown small or inconsistent correlations between testosterone levels and male orgasm experience, as well as sexual assertiveness in both sexes. Insufficient levels of testosterone in men may lead to abnormalities including frailty, accumulation of adipose fat tissue within the body, anxiety and depression, sexual performance issues, and bone loss. In humans, testosterone plays a key role in the development of male reproductive tissues such as testicles and prostate, as well as promoting secondary sexual characteristics such as increased muscle and bone mass, and the growth of body hair. Lower-than-normal testosterone levels typically only cause symptoms in males. If any of these organs — your hypothalamus, pituitary gland or gonads — aren’t working normally, that can cause abnormal testosterone levels. High LH levels can be a sign that your sex organs aren’t producing enough steroid hormones needed for a reproductive process to take place. Except for abnormally high levels of FSH in kids, which can cause early puberty, abnormal levels of FSH — whether too high or too low — usually point to hypogonadism. If the adenoma is of a certain size or is growing, it can put pressure on your pituitary gland or block blood flow to it. This condition is called hypogonadotropic-hypogonadism, and it’s usually caused by issues with your pituitary gland or hypothalamus. Lower-than-normal FSH levels usually lead to incomplete development during puberty. This prevents normal sexual development in children and normal function of the testicles or ovaries in adults. The plasma protein binding of testosterone is 98.0 to 98.5%, with 1.5 to 2.0% free or unbound. In the final and rate limiting step, the C17 keto group androstenedione is reduced by 17β-hydroxysteroid dehydrogenase to yield testosterone. The first step in the biosynthesis involves the oxidative cleavage of the side-chain of cholesterol by cholesterol side-chain cleavage enzyme (P450scc, CYP11A1), a mitochondrial cytochrome P450 oxidase with the loss of six carbon atoms to give pregnenolone. In contrast to testosterone, DHEA and DHEA sulfate have been found to act as high-affinity agonists of these receptors. In the bones, estradiol accelerates ossification of cartilage into bone, leading to closure of the epiphyses and conclusion of growth. The prostate gland is a walnut-sized gland that surrounds a portion of the urethra and produces some of the fluid in semen. From here, sperm are transported to the vas deferens. Next to each testicle, the epididymis is a tube where sperm is stored. It has genes — half are from the egg and half are from the sperm. Each ejaculation can carry up to 500 million sperm. In the hepatic 17-ketosteroid pathway of testosterone metabolism, testosterone is converted in the liver by 5α-reductase and 5β-reductase into 5α-DHT and the inactive 5β-DHT, respectively. The conjugates of testosterone and its hepatic metabolites are released from the liver into circulation and excreted in the urine and bile. Androsterone and etiocholanolone are then glucuronidated and to a lesser extent sulfated similarly to testosterone. An additional 40% of testosterone is metabolized in equal proportions into the 17-ketosteroids androsterone and etiocholanolone via the combined actions of 5α- and 5β-reductases, 3α-hydroxysteroid dehydrogenase, and 17β-HSD, in that order. Approximately 50% of testosterone is metabolized via conjugation into testosterone glucuronide and to a lesser extent testosterone sulfate by glucuronosyltransferases and sulfotransferases, respectively. Decline of testosterone production with age has led to interest in androgen replacement therapy. In androgen-deficient men with concomitant autoimmune thyroiditis, substitution therapy with testosterone leads to a decrease in thyroid autoantibody titres and an increase in thyroid's secretory capacity (SPINA-GT). Conflicting results have been obtained concerning the importance of testosterone in maintaining cardiovascular health. It activates genes in Sertoli cells, which promote differentiation of spermatogonia. The levels remain in a pubertal range for a few months, but usually reach the barely detectable levels of childhood by 4–7 months of age. This period affects the femininization or masculinization of the fetus and can be a better predictor of feminine or masculine behaviours such as sex typed behaviour than an adult's own levels.